← Open Payments lookup

KATE RAY: Open Payments

NPI 1073794285 · FORT LEE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,206 in 177 payments from 18 companies in 2025. Trend: 2023 $1,046 · 2024 $3,096 · 2025 $3,206

Food & beverage: $3,078Education: $128
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$505
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)26$417
Vanda Pharmaceuticals Inc.16$328
E.R. Squibb & Sons, L.L.C.17$301
ABBVIE INC.25$285
Teva Pharmaceuticals USA, Inc.12$230
Otsuka America Pharmaceutical, Inc.13$177
Axsome Therapeutics, Inc.7$162
Takeda Pharmaceuticals U.S.A., Inc.11$155
Alkermes, Inc.6$126

Products named: INGREZZA, CAPLYTA, COBENFY, VRAYLAR, FANAPT, REXULTI, TRINTELLIX, Auvelity.

Industry payments across VA — which companies pay providers there.